The Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU) is expanding its statistical and methodology team.
We want to hear from you if you:
1. Enjoy the challenge of researching, developing, and implementing efficient trial methodology that would make a difference in patients’ lives.
2. Seek variety in your work and opportunities to apply your statistical knowledge across multiple therapeutic areas in oncology.
3. Thrive on being part of a multi-disciplinary research team with like-minded statisticians.
Applications are now open for a Trials Methodologist/Senior Trials Methodologist position to join our team of over 20 statisticians. The post offers an excellent opportunity for an enthusiastic and well-motivated statistician to work in a dynamic and supportive academic environment at a leading cancer clinical trials unit.
Key Requirements
The successful applicant will be an experienced and highly motivated statistician interested in researching new statistical methods to improve efficiency in clinical trials and eager to apply their statistical knowledge across various therapeutic areas in oncology. The successful applicant will have a post-graduate qualification in statistics. They should demonstrate a solid understanding of clinical trials and experience in applying statistical methods to real-world data. Familiarity with Bayesian statistics is highly desirable. Effective oral and written communication skills, as well as enthusiasm for collaborating with others from diverse disciplines, are essential.
Department/Directorate Information
ICR-CTSU manages an exciting portfolio of national and international phase II and III clinical trials and an expanding number of early phase I/II cancer trials. You will contribute in shaping the development of methodological innovations and implementing efficient methods in new and ongoing trials, with a specific focus in early phase and adaptive trials. You will work as part of a multi-disciplinary team on trials methodology research and on the statistical development, oversight, and analysis of a number of clinical trials within ICR-CTSU’s portfolio and early phase portfolio in collaboration with external organisation and the Drug Development Unit.